CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse
NCT ID: NCT00275769
Last Updated: 2008-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
860 participants
INTERVENTIONAL
2004-03-31
2006-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In addition, an evaluation of the timesaving and qualitative benefits of the device feature known as Quick Look II (the computer interface screen of the device programmer) will be measured through the use of a questionnaire completed by the health care professionals involved in patient follow-up care.
This is a one-to-one randomized, multicenter, prospective study in which patients receiving new EnPulse pacemaker implants will be randomized to each of three study arms, 1) routine manual follow-up and follow-up using the automatic features; 2) ACM diagnostics detail on or VCM diagnostics detail on; 3) PMOP on / off or PMOP off / on (6 month cycle).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pacemaker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with medical conditions that preclude the testing required by the protocol or limit study participation
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen W. Mester, MD
Role: PRINCIPAL_INVESTIGATOR
Tampa General Hospital
Lawrence S. Rosenthal, MD
Role: PRINCIPAL_INVESTIGATOR
UMass Memorial Health
Raymond Gendreau, MD
Role: PRINCIPAL_INVESTIGATOR
Cite di la Sante de Laval
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anchorage, Alabama, United States
Mobile, Alabama, United States
Fullerton, California, United States
Oceanside, California, United States
Redondo Beach, California, United States
Stanford, California, United States
Colorado Springs, Colorado, United States
Washington D.C., District of Columbia, United States
Brandon, Florida, United States
Daytona Beach, Florida, United States
Orlando, Florida, United States
Sarasota, Florida, United States
Athens, Georgia, United States
Gainsville, Georgia, United States
Chicago, Illinois, United States
Peoria, Illinois, United States
Des Moines, Iowa, United States
Kansas City, Kansas, United States
Worcester, Maine, United States
Burlington, Massachusetts, United States
Petoskey, Michigan, United States
Saint Paul, Minnesota, United States
Jackson, Mississippi, United States
Columbia, Missouri, United States
St Louis, Missouri, United States
Flemington, New Jersey, United States
Newark, New Jersey, United States
Paramus, New Jersey, United States
Albuquerque, New Mexico, United States
Fayetteville, New York, United States
New York, New York, United States
High Point, North Carolina, United States
Akron, Ohio, United States
Cleveland, Ohio, United States
Steubenville, Ohio, United States
Lawton, Oklahoma, United States
Tualatin, Oregon, United States
Altoona, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pawtucket, Rhode Island, United States
Columbia, South Carolina, United States
Greenville, South Carolina, United States
Sioux Falls, South Dakota, United States
Knoxville, Tennessee, United States
Oak Ridge, Tennessee, United States
Forth Worth, Texas, United States
Houston, Texas, United States
Richmond, Virginia, United States
Spokane, Washington, United States
Charleston, West Virginia, United States
Wausau, Wisconsin, United States
North Vancouver, British Columbia, Canada
Kitchener, Ontario, Canada
Toronto, Ontario, Canada
Laval, Quebec, Canada
Québec, Quebec, Canada
Saskatoon, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rosenthal LS, Mester S, Rakovec P, Penaranda JB, Sherman JR, Sheldon TJ, Zeng C, Wang P; CAPTURE Trial Investigators. Factors influencing pacemaker generator longevity: results from the complete automatic pacing threshold utilization recorded in the CAPTURE Trial. Pacing Clin Electrophysiol. 2010 Aug;33(8):1020-30. doi: 10.1111/j.1540-8159.2010.02809.x. Epub 2010 Jun 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
229
Identifier Type: -
Identifier Source: org_study_id